A Prospective Phase II Dose Escalation Study Using IMRT for High Risk N0 M0 Prostate Cancer. ICORG 08-17

NCT00951535 · clinicaltrials.gov ↗
PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
251
Enrollment
NETWORK
Sponsor class

Conditions

Interventions

Sponsor

Cancer Trials Ireland